Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this clinical study are to evaluate the extended safety, tolerance and
acceptability of a vaginal gel formulation when applied in 452 healthy women volunteers. This
vaginal formulation was shown to be well tolerated in a previous smaller clinical study. The
formulation is being developed as a microbicide for the prevention of sexually transmitted
infections (STIs) including HIV.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Laval University
Collaborators:
Canadian Institutes of Health Research (CIHR) Centre Hospitalier de l'Universite Laval (CHUL)